RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ensysce Biosciences Stock

Ensysce Biosciences ROA 2024

Ensysce Biosciences ROA

-3.92

Ticker

ENSC

ISIN

US2936024056

In 2024, Ensysce Biosciences's return on assets (ROA) was -3.92, a -7.73% increase from the -4.25 ROA in the previous year.

Ensysce Biosciences Aktienanalyse

What does Ensysce Biosciences do?

Ensysce Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Ensysce Biosciences's Return on Assets (ROA)

Ensysce Biosciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Ensysce Biosciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Ensysce Biosciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Ensysce Biosciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Ensysce Biosciences stock

What is the Return on Assets (ROA) of Ensysce Biosciences this year?

The Return on Assets (ROA) of Ensysce Biosciences is -3.92 undefined this year.

What was the ROA of Ensysce Biosciences compared to the previous year?

The ROA of Ensysce Biosciences has increased by -7.73% compared to the previous year.

What consequences do high ROA have for investors of Ensysce Biosciences?

A high ROA is advantageous for investors of Ensysce Biosciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Ensysce Biosciences?

A low ROA can be unfavorable for investors of Ensysce Biosciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Ensysce Biosciences affect the company?

An increase in ROA of Ensysce Biosciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Ensysce Biosciences impact the company?

A reduction in the ROA of Ensysce Biosciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Ensysce Biosciences?

Some factors that can influence the ROA of Ensysce Biosciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Ensysce Biosciences important for investors?

The ROA of Ensysce Biosciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Ensysce Biosciences take to improve ROA?

To improve ROA, Ensysce Biosciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Ensysce Biosciences pay?

Over the past 12 months, Ensysce Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ensysce Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Ensysce Biosciences?

The current dividend yield of Ensysce Biosciences is .

When does Ensysce Biosciences pay dividends?

Ensysce Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ensysce Biosciences?

Ensysce Biosciences paid dividends every year for the past 0 years.

What is the dividend of Ensysce Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ensysce Biosciences located?

Ensysce Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ensysce Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ensysce Biosciences from 10/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/24/2024.

When did Ensysce Biosciences pay the last dividend?

The last dividend was paid out on 10/24/2024.

What was the dividend of Ensysce Biosciences in the year 2023?

In the year 2023, Ensysce Biosciences distributed 0 USD as dividends.

In which currency does Ensysce Biosciences pay out the dividend?

The dividends of Ensysce Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ensysce Biosciences

Our stock analysis for Ensysce Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ensysce Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.